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Abstract
Recently, the potential health effects of trans-fatty acid consumption have raised concerns. A few
studies have examined the risk of colorectal cancer with increasing consumption of trans-fatty acids,
but none investigated the risk of rectal cancer, which may have different risk factors than colon
cancer. Our objective was to explore the relationship between trans-fatty acid consumption and distal
colorectal (sigmoid, rectosigmoid, and rectal) cancer using a case-control study of Whites (n=1516)
and African Americans (n=392) in North Carolina from 2001–2006. Matched cases and controls
were interviewed about demographic information, lifestyle factors, and diet. White cases reported
higher mean consumption of trans-fatty acid than White controls, but mean consumption was similar
for African American cases and controls. Relative to the lowest quartile, the highest quartiles of
energy-adjusted trans-fatty acid consumption were positively associated with distal colorectal cancer
for Whites [adjusted ORs for the third and fourth quartiles, respectively: 1.54 (95%CI: 1.12, 2.13)
and 1.45 (95%CI: 1.04, 2.03)]. Consumption was not associated with distal colorectal cancer in
African Americans [adjusted ORs for the third and fourth quartiles: 0.98 (95%CI: 0.47, 2.05) and
0.87 (95%CI 0.42, 1.81)]. In conclusion, high consumption of trans-fatty acids was positively
associated with distal colorectal cancer among Whites.
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Introduction
In the United States, colorectal cancer is the third leading cause of cancer death among both
men and women, accounting for approximately 10% of all cancer deaths each year [1]. Diet is
thought to play a large role in the development of colorectal cancer [2]. Total dietary fat has
been studied as a potential risk factor for colorectal cancer, but no overall association has been
found [3–8]. It is possible, however, that specific types of dietary fat may be associated with
colorectal cancer.
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trans-Fatty acid consumption has been linked to a variety of diseases, including heart disease
and type II diabetes [9,10]. An ecologic study demonstrated relationships between trans-fatty
acids and the rates of prostate, breast, and colon cancer in Europe [11]. Therefore, we
hypothesized that trans-fatty acid might be involved in increasing the risk of developing
colorectal cancer. Other studies have been performed examining the association between
colorectal cancer and trans-fatty acid consumption but the results have been inconsistent
[12–17]. Further, the majority of etiologic studies combine cancers of the colon and rectum,
but the risk factors for these cancers may be distinct. In the EPIC study cohort waist
circumference, waist-hip ratio, and physical inactivity were positively associated with colon
but not rectal cancer [18]. Studies of milk/dairy consumption have also reported different
associations for the two locations (inverse associations were observed for colon but not rectal
cancer) [19,20]. The hypothesis of different risk factors was also supported by a review of
physical activity and cancers of the colon and rectum [21,22].
In addition to combining cancers of the colon and rectum, few studies have explored whether
the association differs by race. Previous studies of Whites and African Americans residing in
North Carolina demonstrated that these populations have different consumption patterns for
“fats, oils, and snacks,” a grouping that included trans-fatty acids [23]. We used data from the
North Carolina Colon Cancer Study II (NCCCS II) to investigate the potential association
between consumption of trans-fatty acids and distal colorectal cancer by race.
Materials and Methods
Study population
The NCCCS II is a population-based, matched case-control study conducted in central and
eastern North Carolina. Subjects were enrolled from 33 counties representing urban, suburban,
and rural areas of the state. The study received human subjects approval from the University
of North Carolina School of Medicine Institutional Review Board.
Cases were identified using the rapid case ascertainment system of the North Carolina Central
Cancer Registry. Individuals with a first diagnosis of histologically confirmed sigmoid colon,
rectosigmoid, or rectal adenocarcinoma between May 2001 and September 2006 were
classified as potential cases. Using this approach, the Registry identifies potential cases and
sends their pathology report to study investigators within two to four weeks of an individual’s
diagnosis. To be eligible for the study, subjects had to be between the ages of 40 and 80
(individuals under the age of 40 with colorectal cancer were assumed to be unrepresentative
of most colorectal cancer cases), reside in one of the 33 counties included in the study, be able
to give informed consent, be able to complete an interview, have a North Carolina driver’s
license or identification card (if under the age of 65), and had no denial by the primary physician
for us to contact them.
Potential cases were sent a letter describing the study, which was followed by a call from a
race-matched enrollment specialist. The specialist explained the study and answered any
questions that the patient had about participating. Potential cases who could not be reached
were called again during various times/days of the week. A maximum of fifty attempts were
made by phone and two letters about the study and our desire to get in-touch were mailed. If
the patient consented, then the enrollment specialist scheduled an in-person interview. On
average, interviews took place within five months of diagnosis. White cases were under-
sampled for recruitment in order to increase the proportion of African American cases in the
study population.
Controls, individuals with no diagnosis of colorectal cancer, were selected from two sources:
North Carolina Department of Motor Vehicles records (for controls under the age of 65) and
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Center for Medicare and Medicaid Services records (for controls age 65 and older).
Randomized recruitment[24] was used to sample controls according to the expected age (within
5-year strata), sex, and race distribution of the cases. Potential controls were contacted in a
manner similar to that of the cases. The same eligibility requirements (with the exception of
physician contact) were applied to the control population.
Data collection
Data were collected by trained nurse interviewers at the person’s house or another convenient
location. Individuals were offered a $25 incentive for participation in the study. All participants
were queried regarding demographic information, lifestyle factors, and medical history.
Information on physical activity was ascertained using a seven-day recall previously validated
in a group of men and women aged 20–59 [25–27]. Height and weight were measured at the
interview, and participants were also asked about their weight one year prior to diagnosis (for
cases) or interview (for controls).
Dietary information was collected using the Diet History Questionnaire (DHQ) developed at
the National Cancer Institute (NCI) [28–30]. This food frequency questionnaire allows
participants to choose the portion size and frequency of foods that they consume and also
accounts for differences in types of fats added during cooking., Information was collected on
the types and amounts of fats added before consumption as well. In order to capture usual diet
across seasons, we asked participants to use a reference period of the year prior to cancer
diagnosis (for cases) or interview (for controls). Diet*Calc, a program developed by the NCI
to accompany the DHQ, was used to determine average daily nutrient intakes, including
trans-fatty acids, for each subject. The Diet*Calc program applies information from a nutrient
database to the food frequency/portion size data collected by the questionnaire. trans-Fatty
acid values were added to the Diet*Calc program in 2003 based on information from the
University of Minnesota’s Nutrient Data System for Research (NDS-R). Further information
can be found elsewhere [31].
Data analysis
Participants who self-identified their race as “other” or were missing information on race were
removed from the analysis (n=61). Participants with extreme or implausible dietary values
[<800 or >5000 kcal/day for men (n=74) and <600 or >4000 kcal/day for women (n=34)] were
also excluded from the analysis.
Energy-adjustment allowed us to examine trans-fatty acid consumption uncorrelated with total
energy intake, which was necessary because total energy intake was correlated with trans-fatty
acid consumption (correlation was 0.77 for Whites and 0.81 for African Americans) and was
a risk factor for disease (a logistic regression model controlling for possible covariates showed
energy intake to be associated with distal colorectal cancer). We used the residual method to
model trans-fatty acid consumption adjusted for energy intake. Specifically, the values of each
participant’s energy-adjusted intakes were estimated based on a regression model in which
energy intake was the independent variable and trans-fatty acid intake was the dependent
variable [32]. trans-Fatty acid consumption was then categorized into quartiles based on the
energy-adjusted consumption of the control group.
We used unconditional logistic regression to investigate the relationship between trans-fatty
acid consumption and distal colorectal cancer. Offset terms were included to account for the
sampling probabilities used to identify eligible cases and controls [24]. Non-steroidal anti-
inflammatory drug (NSAID) use and sex were assessed as potential effect measure modifiers,
using tests of homogeneity and likelihood ratio tests comparing models with and without
interaction terms (with an a priori P-value cut-off for retention in the final model of <0.15).
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These variables were chosen because similar studies found that the association between
trans-fatty acid consumption and colorectal cancer differed within strata of these variables
[14,15]. In addition, NSAID use has previously been inversely associated with colon cancer
[33] and could play a biologic role if trans-fatty acid consumption promotes inflammation
[34]. Likelihood ratio tests examining NSAID use as an effect measure modifier had P-values
of 0.36 in Whites and 0.90 in African Americans. P-values for likelihood ratio tests examining
sex as an effect measure modifier were 0.26 in Whites and 0.42 in African Americans. The
following variables, which have been previously associated with colorectal cancer and may be
associated with trans-fatty acid consumption, were assessed as potential confounders using
backwards elimination with a 10% change-in-estimate criterion: body mass index (BMI) one
year prior to diagnosis/interview (normal, overweight, and obese according to the World Health
Organization cut-points), MET-minutes per day of physical activity (quartiles based on the
control group), at least one first-degree family member with a diagnosis of colorectal cancer
(yes, no), NSAID use (never, rare, and frequent), smoking status (never, former, and current
smoker), highest level of education (high school degree or less, some college, and college
graduate/advanced degree), alcohol consumption (0 drinks/day, <1 drink/day, ≥1 drink/day),
daily consumption of total fatty acids (energy-adjusted; quartiles based on the control group),
saturated fatty acids consumption (quartiles based on the control group), calcium intake
(dietary and supplemental; quartiles based on the control group), vegetable consumption
(quartiles based on the control group), and red meat consumption (quartiles based on the control
group). Although the actual number of missing observations was small, multiple imputation
was performed to impute data for potential confounding variables with missing observations
(physical activity: 5.2% missing, BMI one year prior: 3.7% missing, family history: 2.3%
missing, smoking status: 0.9% missing, and NSAID use: 0.6% missing). The imputed data
were generated based on values from other observations in the dataset without missing
information. Characteristics that met our change-in-estimate criterion in one or both racial
groups were included in the final models [highest level of education completed (among both
groups), BMI one year prior to interview (among Whites), energy-adjusted total fatty acid
consumption (among African Americans) family history of colorectal cancer (among African
Americans)]. In addition, the final model included a term for total energy intake, a term for
stratum of matching variable (sex and five-year categories of age), and an offset term (a
constant within groups of age, sex, and race) to account for sampling probabilities [24]. The
analysis was repeated using the data prior to imputation. The results were similar and therefore
only the results of the models using multiple imputation are given.
In addition, we investigated the relationship between three specific tumor locations (sigmoid
colon, rectosigmoid, or rectum) and trans-fatty acid consumption. Cases without a specified
location were excluded from this analysis (n=12). This analysis was performed using
multinomial logistic regression. A limitation of this model is that we were not able to include
offset terms. Potential confounders were reassessed for this model using backwards elimination
with a 10% change-in-estimate criterion.
Results
Among those who were eligible to participate in the study, 17% of cases and 26% of controls
refused and 8% of cases and 18% of controls were untraceable or not reached. A total of 2061
people completed interviews (1045 cases and 1016 controls), yielding study cooperation rates
(interviewed/(interviewed+refused)) for cases and controls of 81% and 68% (Whites: 81% and
68%; African Americans: 82% and 65%) and response rates (interview/eligible) of 74% and
56% (Whites: 76% and 58%; African Americans: 70% and 46%), respectively.
Characteristics of the study population are shown according to case-control status and race in
Table 1. Most of the study participants were at least 60 years old. A larger proportion of White
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and African American cases had a high school degree or less compared with controls (19.4 and
35.2% compared with 12.1 and 26.4%, respectively). Both White and African American cases
were more likely than controls to be obese (36.7 and 49.5% versus 28.3 and 41.3%,
respectively). Cases had a higher average total energy intake compared to controls [mean
(standard deviation) kcal/day of 2280.5 (855.8) versus 2158.0 (813.6)]. African American
cases and controls reported higher total energy intakes than corresponding White cases and
controls.
White cases had a higher mean intake of unadjusted trans-fatty acid than controls [mean
(standard deviation) grams/day of 6.1 (3.0) and 5.4 (2.9), respectively] (t-test P-value<0.001).
The median intakes in grams/day (interquartile range) among Whites were 5.6 (3.8, 7.7) for
cases and 4.9 (3.2, 7.0) for controls (Wilcoxon rank-sum test P-value<0.001). Intakes were
similar among African American cases and controls: a mean of 6.3 grams/day for both cases
and controls (standard deviation of 3.3 and 3.5, respectively) (t-test P-value 0.97) and a median
of 5.7 grams/day (Wilcoxon rank-sum test 0.84). We determined which food items contributed
most to trans-fatty acids consumption among both Whites and African Americans. The foods
that each contributed over 5% to the White study population’s grams of trans-fatty acid intake
were as follows: margarine (9.7%), biscuits (7.0%), fried fish (6.6%), fried potatoes (6.6%),
crackers (5.8%), cookies/brownies (5.4%), and bread/rolls/croissants (5.1%). African
Americans had fewer foods contributing more than 5% to the total trans-fatty acid consumption
of the study population. Nonetheless, the major contributors were similar to those seen for
Whites. They included: fried fish (12.6%), margarine (8.7%), biscuits (8.0%), fried potatoes
(5.5%), and cookies/brownies (5.0%).
We modeled the association between total trans-fatty acid intake, prior to energy adjustment,
and distal colorectal cancer, controlling for variables found to be confounders of the non-energy
adjusted model (physical activity, education, calcium intake, and meat consumption), matching
factors (sex and age) and offset terms. There was a positive relationship between increasing
trans-fatty acid consumption and distal colorectal cancer for Whites. Odds ratios comparing
the second, third, and fourth quartiles to the lowest quartile of consumption were 1.66 (95%
CI: 1.20, 2.31), 1.74 (95%CI: 1.22, 2.48) and 2.44 (95%CI: 1.64, 3.65), respectively. For
African Americans the corresponding odds ratios were 1.22 (95%CI: 0.59, 2.52), 1.52 (95%
CI: 0.68, 3.39) and 0.69 (95%CI: 0.30, 1.60), respectively.
High consumption of energy-adjusted trans-fatty acids was positively associated with distal
colorectal cancer for Whites (Table 2). The odds ratios for the energy-adjusted models were
slightly decreased from those seen in the non-energy adjusted models. Both the third and fourth
quartiles of trans-fatty acid consumption remained positively associated with distal colorectal
cancer [third quartile: odds ratio 1.54 (95%CI: 1.12, 2.13); fourth quartile: odds ratio 1.45 (95%
CI: 1.04, 2.03)]. A similar association was not seen for African Americans (Table 2) with the
odds ratio comparing the fourth quartile to the lowest quartile being 0.87 (95%CI: 0.42, 1.81).
We further examined the relationship looking at specific types of trans-fatty acid: 16:1 trans-
hexadecenoic acid. 18:1trans-octadecenoic acid, and 18:2trans-octadecadienoic acid. The
same relationships seen in total trans-fatty acid consumption were evident for these trans-fatty
acid subtypes (Table 2).
Finally, we explored the relationships between consumption of trans-fatty acids and tumor
location (sigmoid colon, rectosigmoid, or rectum). Although the results were more imprecise
due to smaller numbers in each of the categories, in Whites the trend towards a positive
association was seen in the adjusted odds ratios for all three locations with moderate/high
trans-fatty acid consumption compared to the lowest levels of consumption (Table 3). Again,
no association was seen among African Americans (Table 3). Overall, associations with
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trans-fatty acid consumption did not clearly differ in either racial group based on the location
of the cancer.
Discussion
In this study, distal colorectal cancer was positively associated with consumption of trans-fatty
acids among Whites. Compared with the lowest quartile of consumption, the two highest
quartiles of trans-fatty acid consumption had the largest increase in relative risk of colorectal
cancer. This was true for all subtypes of trans-fatty acid (16:1 trans hexadecenoic fatty acid,
18:1 trans octadecenoic fatty acid, and, 18:2 trans octadecadienoic fatty acid). In addition,
increased consumption of trans-fatty acids was also positively associated with cancer for all
three locations: the sigmoid colon, rectosigmoid, and rectum.
Among African Americans there was no association between distal colorectal cancer and
increased consumption of trans-fatty acid. This was true among all subtypes of trans-fatty acid
and all locations examined. We cannot explain why the association differs from that seen in
Whites. The results presented for African Americans could be the result of sampling error
among the control population, inaccurate dietary reporting, or residual confounding by an
unknown factor. It could also be reflective of true dietary differences between Whites and
African Americans. There were differences in the foods that contributed the largest percentage
of trans-fatty acids; in particular, fried fish accounted for a larger proportion of the trans-fatty
acids consumed by African Americans than Whites. Possibly, the method of frying the fish
utilized less trans-fatty acids than expected, resulting in misclassification of trans-fatty acid
consumption. It is possible that the food frequency questionnaire we utilized did not adequately
represent the true diet of African Americans living in North Carolina. This could also be a
chance finding. Additional studies in larger samples of African Americans will be useful in
further elucidating these associations.
Previous studies have reported inconsistent results for the association of trans-fatty acid
consumption and colorectal cancer [12–17] and adenomas [35–37]. Two cohort studies
conducted in women found no association between trans-fatty acid consumption and colorectal
cancer. These studies also report no difference in the association by cancer location [12,17].
However, two case-control studies found an association with colon [15] and colorectal [14]
cancer among women. Neither study detected an association among men. Two other case-
control studies reported no overall association [13,16]. One of these was conducted among a
similar population in North Carolina as part of the NCCCS I [16], but in that study only
individuals with colon cancer were enrolled as cases. This study also examined the association
by race but showed no association for either Whites or African Americans. Only three studies
examined the association between trans-fatty acids and colorectal adenomas [35–37]. Two
utilized food groupings and reported colorectal adenomas to be associated with consumption
of “sweetened baked goods” but concluded there was no association with overall trans-fatty
acids [36–37]. The other study was a cross-sectional study taking place in North Carolina
[35]. It reported a positive association between the highest quartile of trans-fatty acid
consumption and the prevalence of colorectal adenomas. Our study is different from these
previous works in that we concentrate on the sigmoid colon, rectosigmoid, and rectum and
examine if the associations differ by race.
There are several potential mechanisms by which trans-fatty acid consumption could affect
the risk of distal colorectal cancer. First, trans-fatty acids themselves could irritate the colonic
mucosa. A study of male rats found the fat excretion:intake ratio was two times higher for rats
fed trans-fatty acid compared to rats fed cis-fatty acids [38] Though to our knowledge no
similar studies have been performed in humans, it is possible that trans-fatty acids present in
fecal matter irritate the distal colon and rectum, resulting in increased proliferation,
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inflammation, and oxidative stress. Higher levels of a well-accepted oxidative stress marker
[urinary 8-iso-PGF(2alpha)] was found in participants of a small randomized trial who
consumed 6.0 grams of trans-fatty acid per day for six weeks when compared with those given
a diet free of trans-fatty acids over the same period [39]. In addition, systemic inflammatory
markers [soluble tumor necrosis factor α receptor 1 and 2 (sTNF-R1 and R2)] have been
positively associated with trans-fatty acid intake in women from the Nurses’ Health Study
cohort[34]. Bile acids resulting from the digestion of trans-fatty acids may also play a role.
Some studies have shown that bile acids in the colon are metabolized by bacteria, producing
carcinogenic compounds and increasing cellular proliferation [40,41]. Insulin resistance is
another plausible underlying mechanism that might explain the roles of trans fatty acids in the
development of distal colorectal cancer. Studies have found that trans-fatty acid intake
increased insulin sensitivity in subjects with diabetes or insulin resistance, although this effect
was not seen in healthy subjects [42]. Increased insulin stimulates cell signaling pathways that
increase cellular proliferation [43], which has been positively associated with the incidence of
colorectal cancer in animals [44].
Currently, there is a campaign to have trans-fatty acids removed from foods. Certain localities,
including New York City, have banned trans-fatty acids from commercial food outlets [45,
46]. As of January 1, 2006, all food products sold in the United States were required to list the
amount of trans-fatty acids in the nutritional information on packaging [47]. Although
enrollment of the present study did not end until August of 2006, we do not believe that the
removal and labeling of foods affected our results for a few reasons. First, it is not consumption
immediately prior to the development of cancer but more distant diet that is likely to be
etiologically relevant, so diet during this period of eight months is not likely to have drastically
affected the biologic changes leading to cancer. Second, the Diet*Calc system uses trans-fatty
acid values for foods prior to January 2006 (when many companies began removing them from
their foods) so the amount of trans-fatty acids in the food supply matches that of the amount
we assigned to each food participants reported consuming.
This study has certain strengths. The study was large, population-based, and used dietary
instruments previously validated in other study populations [28]. The interviews were
conducted in-person and captured information on a wide array of potential colorectal cancer
risk factors. Many of the risk factors presented in Table 1 have distributions in the direction
we would expect, thereby giving further confidence in the study population. There are some
limitations as well. First, although there was a large number of White participants, the number
of African Americans in our study population was small, contributing to imprecision in risk
estimates. As in all case-control study designs, there is the potential for selection and recall
bias. Attempts to minimize selection bias included utilizing population-based registries and
trying to maximize participation rates with multiple follow-up calls and letters. However, the
response rates were lower for controls than cases. This is especially true for African American
controls, who had a response rate of 46%. If controls who refused to participate had trans-fatty
acid intakes different than controls who agreed to participate, selection bias could have been
introduced into the study. Recall bias would be present if cases recalled their trans-fatty acid
consumption differently than controls. This would be unlikely because individuals would have
to know which foods contribute to trans-fatty acid intake. Due to the inconsistency of previous
research on this topic, it is unlikely cases would attribute their cancer to trans-fatty acid
consumption. However, it is possible that cases and controls differently remember consuming
unhealthy foods and therefore report consumption of foods containing trans-fatty acids in a
varied manner. Also, the food frequency questionnaire grouped all foods of a certain type
together although the amounts of trans-fatty acids may actually vary within each type of food
based on the brand, preparation, etc. Thus, we were unable to discern if people eating certain
foods had more or less trans-fatty acids in their diet than people eating different brands of a
similar food. In addition, we were not able to separately examine the association for natural
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and synthetic sources of trans fatty acids. It is possible that these two sources may have different
effects on the risk of distal colorectal cancer. Moreover, although the NCI DHQ has been
validated with regards to total fatty acids, saturated fatty acids, polyunsaturated fatty acids, and
other nutrients [28], it has not been validated specifically for trans fatty acid consumption.
Finally, trans fatty acid consumption may simply be acting as a marker for an unhealthy diet.
We attempted to reduce this bias by including other markers of healthy/unhealthy behaviors
in the model as well, such as energy intake and physical activity.
In conclusion, we have demonstrated that increased consumption of trans-fatty acid is
associated with an increased risk of cancers in the sigmoid colon, rectosigmoid, and rectum in
Whites. There was no association among African Americans. This research contributes to the
growing literature supporting negative health effects of trans-fatty acid. Reductions in
consumption of trans-fatty acids and their removal from foods should be advocated.
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